Hydroxychloroquine does not benefit adults hospitalized with COVID-19
The trial began after lab studies and preliminary reports suggested that hydroxychloroquine might have promise in treating SARS-CoV-2.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: American Health | COVID-19 | Hydroxychloroquine | National Institutes of Health (NIH) | SARS | Study